Incidence of xeroderma pigmentosum in Larkana, Pakistan: A 7-year study

British Journal of Dermatology

Volumn 152, Issue 3, 2005, Pages 545-551

  Bhutto, Abdul Manan ^a,c   Shaikh, A ^a   Nonaka, S ^b  

^a Shaheed Mohtarama Benazir Bhutto Medical University   (Pakistan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

^c NONE   (Pakistan)

Author keywords

Clinical observations; Larkana; Pakistan; Xeroderma pigmentosum

Indexed keywords

ANTIBIOTIC AGENT; STEROID; SUNSCREEN;

ACTINIC KERATOSIS; ADOLESCENT; ADULT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CHILD; CLINICAL ARTICLE; CONJUNCTIVITIS; CORNEA DISEASE; DNA REPAIR; FEMALE; HUMAN; KERATITIS; KERATOACANTHOMA; LENTIGO; MALE; PAKISTAN; PHOTOPHOBIA; PRIORITY JOURNAL; RACE; SKIN NODULE; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET RADIATION; VISUAL IMPAIRMENT; WELFARE; XERODERMA PIGMENTOSUM;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; EYE DISEASES; FACIAL DERMATOSES; FEMALE; HUMANS; INCIDENCE; MALE; PAKISTAN; SKIN NEOPLASMS; XERODERMA PIGMENTOSUM;

EID: 17544371196     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06311.x     Document Type: Article

References (27)

1. Hebra F, Kaposi M. On Diseases of the Skin Including the Exanthemata, Vol. 3. (Tay W, trans.). London: The New Sydenham Society, 1874; 61:252-8.
2. Reed WB, Landing B, Sugarman G et al. Xeroderma pigmentosum. Clinical and laboratory investigation of its basic defect. JAMA 1969; 207:2073-9.
3. Thompson LH. Nucleotide excision repair: its relation to human disease. In: DNA Repair in Higher Eukaryoies (Nickoloff JA, Hoekstra M, eds), Vol. 2. Totowa, NJ: Humana Press, 1998; 335-93.
4. Svoboda DL, Briley LP, Vos J-HM. Defective bypass replication of a leading strand cyclobutane thymine dinier in xeroderma pigmentosum variant cell extracts. Cancer Res 1998; 58:2445-8.
5. Robbins JH, Kraemer KH, Lutzner MA et al. Xeroderma pigmeniosum: an inherited disease with sun sensitivity, multiple cutaneous neoplasms and abnormal DNA repair. Ann Intern Med 1974; 80:221-48.
6. Neel JV, Kodai M, Brewer R et al. The incidence of consanguineous inatings in Japan: with remarks on the estimation of comparative gene frequencies and the expected rate of appearance of induced recessive mutations. Am J Hum Genet 1949; 1:156-78.
7. Thielmann HW, Edler L, Popanda O et al. Xeroderma pigmentosum patients from the federal republic of Germany: decrease in post-UV colony-forming ability in 30 xeroderma pigmentosum fibroblast strains is quantitatively correlated with a decrease in DNA-incising capacity. J Cancer Res Clin Oncol 1985; 109:227-40.
8. Pawsey SA, Magnus IA, Ramsay CA. Clinical, genetic, and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum. Q J Med 1979; 190:179-210.
9. Hashem N, Bootsma D, Keijzer W et al. Clinical characteristics, DNA repair, and complementation groups in xeroderma pigmentosa patients from Egypt. Cancer Res 1980; 40:13-18.
10. Fischer E, Thielmann HW, Neundorfer B et al. Xeroderma pigmentosum patients from Germany: clinical symptoms and DNA repair characteristics. Arch Dermatol Res 1982; 274:229-47.
11. Kraemer KH, Slor H. Xeroderma pigmentosum. Clin Dermatol 1985; 3:33-69.
12. Hwang SW, Yoo YE, Kim YP. The genetics and clinical studies of xeroderma pigmentosum. Korean J Dermalol 1982; 20:879-84.
13. Park SD, Chung HY. Characterization of a Korean xeroderma pigmentosum cell strain, XPISE, by somatic cell hybridization and complementation studies. Korean J Genelic 1982; 4:69-78.
14. Jiang Z, Hu Y, Chen Q, Yang L. Study of DNA repair enzyme system. I. Ultraviolet induced H-TdR unscheduled incorporation in xeroderma pigmentosum lymphocytes. Acta Genet Sin 1981; 8:310-15.
15. Goyal JL, Rao VA, Srinivasan R et al. Octilocutaneous manifestations in xeroderma pigmentosa. Br J Ophthalmol 1994; 78:295-7.
16. Cleaver JE, Carter DM. Xeroderma pigmentosum variants: influence of temperature on DNA repair. J Invest Dermatol 1973; 60:29-32.
17. Takebe H, Nishigori C, Satoh Y. Genetics and skin cancer of xeroderma pigmentosum in Japan. Jpn J Cancer Res (Gann) 1987; 78:1135-43.
18. Cleaver JE, Kraemer KH. Xeroderma pigmentosum and Cockayne syndrome. In: The Metabolic and Molecular Bases of Inherited Disease (Scriver CR, Beaudet AL, Sly WS, Valle D, eds), Vol. III. New York: McGraw-Hill, 1995; 4393-419.
19. Nishigori C, Moriwaki S, Takebe H et al. Gene alterations and clinical characteristics of xeroderma pigmentosum group A patients in Japan. Arch Dermatol 1994; 130:191-7.
20. Kraemer KH, Lee MM, Andrews AD, Lambert WC. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol 1994; 130:1018-21.
21. Kraemer KH, Lee MM, Scotlo J. Xeroderma pigmentosum. Cutaneous, ocular and neurologic abnormalities in 830 published cases. Arch Dermatol 1987; 123:241-50.
22. Lynch HT, Anderson DE, Smith JL et al. Xeroderma pigmentosum, malignant melanoma, and congenital icthyosis. A family study. Arch Dermatol 1967; 96:625-35.
23. Robbins JH. Xeroderma pigmentosum: defective DNA repair causes skin cancer and neurodegeneration. JAMA 1988; 260:384-8.
24. English JSC, Swerdlow AJ. The risk of malignant melanoma, internal malignancy and mortality in xeroderma pigmentosum patients. Br J Dermatol 1987; 117:457-61.
25. Moore C, Iverson PC. Xeroderma pigmentosum. Cancer 1954; 7:377-82.
26. Cleaver JE, Zelle B, Hashem N. Xeroderma pigmentosum patients from Egypt. II. Preliminary correlations of epidemiology, clinical symptoms and molecular biology. J Invest Dermatol 1981; 77:96-101.
27. Johnson MW, Skuta GL, Kincaid MC et al. Malignant melanoma of the iris in xeroderma pigmentosum. Arch Ophthalmol 1989; 107:402-7.